2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Wednesday, November 8, 2017

9:00AM-10:30AM: Abstract Number: 2909

Only Very High Radiographic Progression Affects HAQ-DI, Results from the Swiss Scqm Cohort

Rheumatoid Arthritis – Clinical Aspects VI: Comorbidities of Rheumatoid Arthritis

9:00AM-10:30AM: Abstract Number: 2900

Osteoarthritis-Associated Calcium-Containing Crystals and Biomaterial Microparticles Both Drive M1 Macrophage Polarization in a Syk and MAP Kinase-Dependent Manner

Metabolic and Crystal Arthropathies II: Mechanisms of Crystal Inflammation and Metabolism

9:00AM-10:30AM: Abstract Number: 2922

Outcomes of Lupus Nephritis in Vulnerable Populations

Systemic Lupus Erythematosus – Clinical Aspects and Treatment V: Longterm Outcomes

9:00AM-10:30AM: Abstract Number: 2995

Pathogens in the Inflammatory Process of Periodontal Disease and Juvenile Idiopathic Arthritis

ACR/ARHP Combined: Pediatrics

9:00AM-10:30AM: Abstract Number: 2997

Patient and Family Reported Psychosocial Areas of Concern within Pediatric Rheumatology: Quality Improvement Data and Implications for Practice

ACR/ARHP Combined: Pediatrics

9:00AM-10:30AM: Abstract Number: 2890

Performance of Machine Learning Methods Using Electronic Medical Records to Predict Varicella Zoster Virus Infection

Health Services Research II: Methods and Technology in Care and Research

9:00AM-10:30AM: Abstract Number: 2892

Persistently Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients

Health Services Research II: Methods and Technology in Care and Research

9:00AM-10:30AM: Abstract Number: 2895

Predictors of Hospitalization, Length of Stay and Costs of Care Among Children with Juvenile Dermatomyositis in the United States

Health Services Research II: Methods and Technology in Care and Research

9:00AM-10:30AM: Abstract Number: 2996

Resilience and Transition Readiness in Pediatric SLE Patients

ACR/ARHP Combined: Pediatrics

9:00AM-10:30AM: Abstract Number: 2907

Salivary Gland Enlargement in IgG4-Related Disease Is Associated with Multiorgan Involvement and Higher Basal Disease Activity

Miscellaneous Rheumatic and Inflammatory Diseases II

9:00AM-10:30AM: Abstract Number: 2903

Serum CC-Chemokine Ligand 18 Level Is a Potential Biomarker of Disease Activity in IgG4-Related Disease

Miscellaneous Rheumatic and Inflammatory Diseases II

9:00AM-10:30AM: Abstract Number: 2928

STAT3 As an Important Integrator of Profibrotic Pathways in Systemic Sclerosis

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics II

9:00AM-10:30AM: Abstract Number: 2894

Synchronous Telemedicine Care in Rheumatology for a Dispersed Veterans Affairs Health System

Health Services Research II: Methods and Technology in Care and Research

9:00AM-10:30AM: Abstract Number: 2905

TET2 Mutation Is Significantly Associated with the Development of Autoimmune Disorder in Patients with Myelodysplastic Syndrome

Miscellaneous Rheumatic and Inflammatory Diseases II

9:00AM-10:30AM: Abstract Number: 2918

The Appearance of IgA RF Followed By IgG RF Is Associated with Transition to Classifiable RA in a Large Preclinical RA Cohort

Rheumatoid Arthritis – Human Etiology and Pathogenesis II

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].